(3R,4R,5S)-4-Acetamido-5-(((3-chloro-[1,1'-biphenyl]-4-yl)-methyl)amino)-3-(pentan-3-yloxy)cyclohex-1-enecarboxylic Acid

ID: ALA3342483

Chembl Id: CHEMBL3342483

PubChem CID: 85468896

Max Phase: Preclinical

Molecular Formula: C27H33ClN2O4

Molecular Weight: 485.02

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCC(CC)O[C@@H]1C=C(C(=O)O)C[C@H](NCc2ccc(-c3ccccc3)cc2Cl)[C@H]1NC(C)=O

Standard InChI:  InChI=1S/C27H33ClN2O4/c1-4-22(5-2)34-25-15-21(27(32)33)14-24(26(25)30-17(3)31)29-16-20-12-11-19(13-23(20)28)18-9-7-6-8-10-18/h6-13,15,22,24-26,29H,4-5,14,16H2,1-3H3,(H,30,31)(H,32,33)/t24-,25+,26+/m0/s1

Standard InChI Key:  LLHTUGRWLRRIHA-JIMJEQGWSA-N

Associated Targets(non-human)

NA Neuraminidase (126 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NA Neuraminidase (159 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NA Neuraminidase (2284 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NA Neuraminidase (1107 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 485.02Molecular Weight (Monoisotopic): 484.2129AlogP: 4.96#Rotatable Bonds: 10
Polar Surface Area: 87.66Molecular Species: ACIDHBA: 4HBD: 3
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 4.15CX Basic pKa: 8.12CX LogP: 2.37CX LogD: 2.31
Aromatic Rings: 2Heavy Atoms: 34QED Weighted: 0.44Np Likeness Score: 0.15

References

1. Xie Y, Xu D, Huang B, Ma X, Qi W, Shi F, Liu X, Zhang Y, Xu W..  (2014)  Discovery of N-substituted oseltamivir derivatives as potent and selective inhibitors of H5N1 influenza neuraminidase.,  57  (20): [PMID:25255388] [10.1021/jm500892k]
2. Ju H, Hou L, Zhao F, Zhang Y, Jia R, Guizzo L, Bonomini A, Zhang J, Gao Z, Liang R, Bertagnin C, Kong X, Ma X, Kang D, Loregian A, Huang B, Liu X, Zhan P..  (2022)  Iterative Optimization and Structure-Activity Relationship Studies of Oseltamivir Amino Derivatives as Potent and Selective Neuraminidase Inhibitors via Targeting 150-Cavity.,  65  (17.0): [PMID:35939763] [10.1021/acs.jmedchem.1c01970]

Source